Literature DB >> 9126656

Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells.

S Seewald1, A Sachinidis, R Düsing, Y Ko, C Seul, P Epping, H Vetter.   

Abstract

Growth of vascular smooth muscle cells (VSMC) plays an important role in the pathogenesis of atherosclerosis and hypertension. Lysophosphatidic acid (LPA), a natural phospholipid is thought to be an important VSMC mitogen and has recently been suggested to play an important role in the development of vascular disease. In the present study, we describe the effects of LPA on intracellular signalling pathways in VSMC. LPA (5 micrograms/ml) induced an increase of cytosolic free calcium concentration ([Ca2+]i) in the presence and absence of extracellular Ca2+ and markedly stimulated the Na+/H+ exchanger. LPA dose-dependently caused a stimulation of the 42-kDa mitogen-activated protein kinase (MAP kinase) isoform with a maximum at 5 min. Also, LPA induced a 5-fold increase in [3H]thymidine incorporation into cell DNA above the basal value, as well as a 42% increase in cell number. Pretreatment of VSMC with pertussis toxin (PTX) (100 ng/ml) for 24 h markedly blunted the LPA-dependent intracellular signalling transduction including the increase in [Ca2+]i, activation of the Na+/H+ exchanger, activation of MAP kinase and the increase in cell DNA synthesis. These findings demonstrate that the effects of LPA on intracellular signalling transduction pathway as well as on VSMC growth are mediated by PTX-sensitive guanosine triphosphate (GTP) binding protein (Gi protein).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126656     DOI: 10.1016/s0021-9150(96)06055-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

2.  Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells.

Authors:  Jiro Sakai; Masahiro Oike; Masakazu Hirakawa; Yushi Ito
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

3.  A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid.

Authors:  N Fukushima; Y Kimura; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Yangxueqingnao particles inhibit rat vascular smooth muscle cell proliferation induced by lysophosphatidic acid.

Authors:  Wei Cai; Yi Xu; Jun-Zhu Chen; Shu-Ru Huang; Zhen-Ya Lu; Zhan-Kun Wang
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

Review 5.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

6.  Ultrasound triggered image-guided drug delivery to inhibit vascular reconstruction via paclitaxel-loaded microbubbles.

Authors:  Xu Zhu; Jun Guo; Cancan He; Huaxiao Geng; Gengsheng Yu; Jinqing Li; Hairong Zheng; Xiaojuan Ji; Fei Yan
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

7.  Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells.

Authors:  Yan-Jun Xu; Paramjit S Tappia; Ramesh K Goyal; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.